Neuroscience and Molecular Pharmacology, Faculty of Biomedical and Life Sciences, West Medical Building, University of Glasgow, Glasgow G12 8QQ, UK.
Biochem Soc Trans. 2009 Dec;37(Pt 6):1375-7. doi: 10.1042/BST0371375.
The regulation of synaptic glutamate receptor and GABA(A)R (gamma-aminobutyric acid subtype A receptor) levels is a key component of synaptic plasticity. Most forms of neuronal plasticity are associated with the induction of the transcription factor zif268 (egr1). Hence, it is predicted that zif268 may regulate transcription of genes associated with glutamate receptors and/or GABA(A)Rs. It turns out that receptor regulation by zif268 tends to be indirect. Induction of zif268 in neurons leads to altered expression of proteasome subunit and proteasome-regulatory genes, thereby changing the capacity of the neuron to degrade synaptic proteins, including receptors and receptor subunits. In addition, zif268 alters the transcription of genes associated with GABA(A)R expression and trafficking, such as ubiquilin and gephyrin. This indirect regulation of receptor turnover is likely to contribute to the delayed, but long-lasting, phases of synaptic plasticity and also to the synaptic dysfunction associated with diseases such as schizophrenia and Alzheimer's disease, where zif268 expression is reduced.
调节突触谷氨酸受体和 GABA(A)R(γ-氨基丁酸 A 型受体)水平是突触可塑性的关键组成部分。大多数形式的神经元可塑性都与转录因子 zif268(egr1)的诱导有关。因此,可以预测 zif268 可能会调节与谷氨酸受体和/或 GABA(A)R 相关的基因的转录。事实证明,zif268 对受体的调节往往是间接的。神经元中 zif268 的诱导会导致蛋白酶体亚基和蛋白酶体调节基因的表达改变,从而改变神经元降解突触蛋白(包括受体和受体亚基)的能力。此外,zif268 还会改变与 GABA(A)R 表达和运输相关的基因的转录,如泛素和 Gephyrin。这种受体周转率的间接调节可能有助于突触可塑性的延迟但持久的阶段,也有助于与精神分裂症和阿尔茨海默病等疾病相关的突触功能障碍,在这些疾病中,zif268 的表达减少。